Abstract
Considerable advances have been made in the understanding of the pathophysiology of epilepsy, which has led to the development of a large number of unique antiepileptic drugs affecting a broader array of pharmacological targets than traditional anticonvulsants. In this paper we discuss seven anticonvulsants that are either recently released, or are being actively investigated in the United States. A review of their pharmacological properties and clinical efficacy is presented.
Original language | English (US) |
---|---|
Pages (from-to) | 267-281 |
Number of pages | 15 |
Journal | Journal of Epilepsy |
Volume | 8 |
Issue number | 4 |
DOIs | |
State | Published - Dec 1995 |
Keywords
- Antiepileptic drugs
- Epilepsy treatment
- Fosphenytoin
- Lamotrigine
- Oxcarbamazepine
- Pharmacokinetics
- Pharmacology
- Tiagabine
- Topiramate
- Vigabatrin
- Zonisamide
ASJC Scopus subject areas
- General Neuroscience
- Clinical Neurology